Passer au contenu principal
Centre intégré universitaire de santé
et de services sociaux de l'Est-de-l'Île-de-Montréal

Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal

Jean Roy, M.D.

Jean Roy

Hématologue-greffeur, Professeur titulaire

L'équipe de l’IHOT

Chercheur-clinicien

Contact

Tél. : 514 252-3404

http://www.chairecellulessouches.com/

Dr Jean Roy est spécialisé dans tous les aspects de la greffe de cellules souches hématopoïétiques, notamment avec des donneurs non apparentés, les régimes de préparation, la mobilisation et collecte de cellules souches et la maladie du greffon contre l’hôte, tant aigüe que chronique.

 

  • Titulaire de la Chaire Maryse et William Brock pour la recherche appliquée en greffe de cellules hématopoïétiques de l'Université de Montréal
  • Entrée en poste à l’Hôpital Maisonneuve-Rosemont : 1998

 

Formation :

  • Fellowship en greffe de cellules souches hématopoïétiques : Université du Minnesota (États-Unis), 1989-1993
  • Résidences en médecine interne et hématologie : Université Laval, Québec et Université McGill, Montréal (Canada), 1985-1989
  • Doctorat en médecine : Université Laval, Québec (Canada), 1979-1984

Découvrez ses publications

  • Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia

    Camille Tessier , Richard LeBlanc , Jean Roy , Sabrina Trudel, Julie Côté, Marc Lalancette, Jean-Samuel Boudreault, Émilie Lemieux-Blanchard, Rayan Kaedbey, Michel Pavic
    DOI 10.1002/cam4.70192 PMID 39225552
    Consulter
  • Assessment of h-index and associated demographic and academic parameters for academic hematologists in Canada

    Daniel Josué Guerra Ordaz , Jean Roy , Imran Ahmad , Mohammed Kaouache, Brandon Ramchatesingh, Sera Whitelaw, Anna Nikonova, Chris Bredeson, Ivan V Litvinov
    DOI 10.3389/fmed.2024.1457366 PMID 39281820
    Consulter
  • Epstein-Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada

    Claire Ratiu, Simon F Dufresne, Stéphanie Thiant , Jean Roy
    DOI 10.3390/curroncol31050211 PMID 38785492
    Consulter
  • Update for cord blood unit selection in hematopoietic stem cell transplantation (workshop SFGM-TC)

    Valérie Dubois, Lucie Blandin, Marion Duclaut, Alix Duquesne, Lionel Faivre, Romain Ferru-Clement , Jean Roy , Alexandre Walencik, Leonardo Magro, Federico Garnier
    DOI 10.1016/j.bulcan.2024.01.009 PMID 38485627
    Consulter
  • Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence

    Sandra Cohen , Nadia Bambace , Imran Ahmad , Jean Roy , Xiaoying Tang, Mei-Jie Zhang, Linda Burns, Frédéric Barabé , Léa Bernard , Jean-Sébastien Delisle , Thomas Kiss , Sylvie Lachance , Denis-Claude Roy , Olivier Veilleux , Guy Sauvageau
    DOI 10.1182/bloodadvances.2023010599 PMID 37467030
    Consulter
  • Young Myeloma Patients: A Systematic Review of Manifestations and Outcomes

    Mégane Tanguay, Christophe Dagenais , Richard LeBlanc , Imran Ahmad , Jean-Sébastien Claveau , Jean Roy
    Consulter
  • Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

    Nabil Yafour, Marie-Anne Couturier, Cécile Borel, Amandine Charbonnier, Tereza Coman, Amandine Fayard, Stavroula Masouridi-Levrat, Ibrahim Yakoub-Agha , Jean Roy
    DOI 10.1016/j.bulcan.2023.03.005 PMID 37045732
    Consulter
  • Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la SFGM-TC

    Micha Srour, Amandine Fayard, Federica Giannotti, Aurelien Giltat, Sarah Guenounou , Jean Roy , Justine Schmitt, Sophie Servais, Tamim Alsuliman, Ibrahim Yakoub Agha, Gaelle Guillerm
    DOI 10.1016/j.bulcan.2022.09.003 PMID 36307323
    Consulter
  • Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge

    Sylvie Lachance , Alex Bourguignon, Josie-Anne Boisjoly, Philippe Bouchard , Imran Ahmad , Nadia Bambace , Léa Bernard , Sandra Cohen , Jean-Sébastien Delisle , Isabelle Fleury , Thomas Kiss , Luigina Mollica , Denis-Claude Roy , Guy Sauvageau , Olivier Veilleux , Justine Zehr, Miguel Chagnon , Jean Roy
    DOI 10.1016/j.jtct.2022.10.003 PMID 36243319
    Consulter
  • Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD

    DOI 10.1016/j.jtct.2022.10.022 PMID 36334654
    Consulter
  • Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

    DOI 10.3390/curroncol29080470 PMID 36005208
    Consulter
  • Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective

    DOI 10.1016/j.jtct.2021.12.005 PMID 34954149
    Consulter
  • Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma

    Jean-Sébastien Claveau , Sophie Savary Bélanger , Imran Ahmad , Jean-Sébastien Delisle , Vincent De Guire , Jean Roy , Richard LeBlanc
    DOI 10.1038/s41408-021-00600-6 PMID 34987163
    Consulter
  • Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study

    Richard LeBlanc , Imran Ahmad , Rafik Terra, Jean-Samuel Boudreault, David Ogez, Kristopher Lamore , Jean-Sébastien Delisle , Nadia Bambace , Léa Bernard , Sandra Cohen , Thomas Kiss , Sylvie Lachance , Séverine Landais, Émilie Lemieux-Blanchard , Guy Sauvageau , Michael Sebag , Denis-Claude Roy , Jean Roy
    DOI 10.1038/s41409-021-01532-2 PMID 34845367
    Consulter
  • UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections

    Maude Dumont-Lagacé, Qi Li , Mégane Tanguay , Jalila Chagraoui, Tibila Kientega, Guillaume B Cardin, Ann Brasey, Assya Trofimov, Cédric Carli , Imran Ahmad , Nadia M Bambace , Léa Bernard , Thomas Kiss , Jean Roy , Denis-Claude Roy , Sébastien Lemieux, Claude Perreault, Francis Rodier, Simon Frédéric Dufresne , Lambert Busque , Sylvie Lachance , Guy Sauvageau , Sandra Cohen , Jean-Sébastien Delisle
    DOI 10.1016/j.bbmt.2020.09.031 PMID 33022376
    Consulter
  • Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors

    DOI 10.1111/ejh.13504 PMID 32749758
    Consulter
  • Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only

    DOI 10.1111/ctr.14099 PMID 32981146
    Consulter
  • Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients

    S Thiant, M M Moutuou, P Laflamme, R Sidi Boumedine, D M Leboeuf , Lambert Busque , Jean Roy , M Guimond
    DOI 10.1038/s41408-020-00374-3 PMID 33149116
    Consulter
  • Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium

    Debra J Bergstrom, Rami Kotb, Martha L Louzada, Heather J Sutherland, Sofia Tavoularis, Christopher P Venner; Myeloma Canada Research Network Consensus Guideline Consortium , Richard LeBlanc , Jean Roy
    DOI 10.1016/j.clml.2020.01.017 PMID 32249195
    Consulter
  • MicroRNAs in graft-versus-host disease: a review of the latest data

    M. Newmarch, E. Kostantin, G. J. Tsongalis, M. Guimond , Jean Roy , V. De Guire , Imran Ahmad
    DOI 10.1038/s41409-019-0764-1 PMID 31796872
    Consulter
  • Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-la...

    Irwin Walker, Tony Panzarella, Stephen Couban, Felix Couture, Gerald Devins, Mohamed Elemary, Geneviève Gallagher, Holly Kerr, John Kuruvilla, Stephanie J Lee , John Moore, Thomas Nevill, Gizelle Popradi , Jean Roy , Kirk R Schultz, David Szwajcer, Cynthia Toze, Ronan Foley; Cell Therapy Transplant Canada
    DOI 10.1016/S2352-3026(19)30220-0 PMID 31958417
    Consulter
  • Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study

    Sandra Cohen , Jean Roy , Sylvie Lachance , Jean-Sébastien Delisle , Anne Marinier , Lambert Busque , Denis-Claude Roy , Imran Ahmad , Nadia M Bambace , Léa Bernard , Thomas Kiss , Philippe Bouchard, Pierre Caudrelier, Sévérine Landais, Fannie Larochelle, Jalila Chagraoui, Bernhard Lehnertz, Sophie Corneau, Elisa Tomellini, Jeroen J A van Kampen, Jan J Cornelissen, Maude Dumont-Lagacé, Mégane Tanguay, Qi Li , Sébastien Lemieux, Peter W Zandstra , Guy Sauvageau
    DOI 10.1016/S2352-3026(19)30202-9 PMID 31704264
    Consulter
  • Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma

    DOI 10.1016/j.bbmt.2019.09.007 PMID 31521818
    Consulter
  • Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis

    Denis-Claude Roy , Sylvie Lachance , Sandra Cohen , Jean-Sébastien Delisle , Thomas Kiss , Guy Sauvageau , Lambert Busque , Imran Ahmad , Léa Bernard , Nadia M Bambace, Radia S Boumédine, Marie-Claude Guertin, Katayoun Rezvani, Stephan Mielke, Claude Perreault , Jean Roy
    DOI 10.1111/bjh.15970 PMID 31135970
    Consulter
  • Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease

    DOI 10.1016/j.leukres.2019.01.002 PMID 30654975
    Consulter
  • Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity

    Erin E Hillhouse, Stéphanie Thiant, Moutuaata M Moutuou, Félix Lombard-Vadnais, Rachel Parat , Jean-Sébastien Delisle , Imran Ahmad , Denis-Claude Roy , Martin Guimond , Jean Roy , Sylvie Lesage
    DOI 10.1016/j.bbmt.2018.09.008 PMID 30244108
    Consulter
  • Cerebral adenovirus endotheliitis presenting as posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation

    DOI 10.1038/bmt.2017.154 PMID 28692025
    Consulter
  • Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients

    S Thiant, M M Moutuou, P Laflamme, R Sidi Boumedine, D M Leboeuf , Lambert Busque , Jean Roy , M Guimond
    DOI 10.1038/bcj.2017.29 PMID 28387753
    Consulter
  • Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation

    DOI 10.1038/bmt.2015.319 PMID 26691426
    Consulter
  • Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

    Irwin Walker, Tony Panzarella, Stephen Couban, Felix Couture, Gerald Devins, Mohamed Elemary, Geneviève Gallagher, Holly Kerr, John Kuruvilla, Stephanie J Lee , John Moore, Thomas Nevill, Gizelle Popradi , Jean Roy , Kirk R Schultz, David Szwajcer, Cynthia Toze, Ronan Foley; Canadian Blood and Marrow Transplant Group
    DOI 10.1016/S1470-2045(15)00462-3 PMID 26723083
    Consulter
  • Thalidomide-prednisone maintenance following autologous stem cell transplant for multiple myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10

    Michael J Kovacs 1, Gwynivere A Davies, Judy-Anne W Chapman, Nizar Bahlis, Michael Voralia , Jean Roy , C Tom Kouroukis, Christine Chen, Andrew Belch, Donna Reece, Liting Zhu, Ralph M Meyer, Lois Shepherd, Keith A Stewart
    DOI 10.1111/bjh.13176 PMID 25302852
    Consulter
  • Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma

    DOI 10.1016/j.bbmt.2012.12.006 PMID 23253556
    Consulter
  • A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial

    A Keith Stewart, Suzanne Trudel, Nizar J Bahlis, Darrell White, Waleed Sabry, Andrew Belch, Tony Reiman , Jean Roy , Chaim Shustik, Michael J Kovacs, Morel Rubinger, Guy Cantin, Kevin Song, Kirsty A Tompkins, Deb C Marcellus, Martha Q Lacy, Jonathan Sussman, Donna Reece , Michael Brundage, Erica L Harnett, Lois Shepherd, Judy-Anne W Chapman, Ralph M Meyer
    DOI 10.1182/blood-2012-09-451872 PMID 23297129
    Consulter
  • Defining the role of sirolimus in the management of graft-versus-host disease: from prophylaxis to treatment

    DOI 10.1016/j.bbmt.2012.06.020 PMID 22771839
    Consulter
  • Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation

    Jean-Philippe Bastien , Jean Roy , Denis-Claude Roy
    DOI 10.1053/j.seminoncol.2012.09.004 PMID 23206844
    Consulter
  • Tandem autologous-allogeneic nonmyeloablative sibling transplantation in relapsed follicular lymphoma leads to impressive progression-free survival with minimal toxicity

    DOI 10.1016/j.bbmt.2011.11.028 PMID 22155507
    Consulter
  • Cardiac tamponade potentially related to sirolimus following cord blood transplantation

    DOI 10.1038/bmt.2011.44 PMID 21399672
    Consulter
  • Allogeneic hematopoietic stem cell collection from a donor with end-stage renal disease

    DOI 10.1038/bmt.2011.31 PMID 21358687
    Consulter
  • Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation

    DOI 10.1016/j.bbmt.2011.04.012 PMID 21601640
    Consulter
  • High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation

    Shih Hann Su, Valérie Martel-Laferrière, Annie-Claude Labbé, David R Snydman, David Kent, Michel Laverdière, Claire Béliveau, Tanya Logvinenko , Sandra Cohen , Sylvie Lachance , Thomas Kiss , Jean Roy
    DOI 10.1016/j.bbmt.2010.10.025 PMID 20977944
    Consulter
  • Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program

    V Lavergne, M Ghannoum, K Weiss , Jean Roy , C Béliveau
    DOI 10.1038/bmt.2010.67 PMID 20383207
    Consulter
  • Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies

    Me-Linh Luong, Charles Filion, Annie-Claude Labbé , Jean Roy , Jacques Pépin, Julia Cadrin-Tourigny, Stéphane Carignan, Donald C Sheppard, Michel Laverdière
    DOI 10.1016/j.diagmicrobio.2010.03.017 PMID 20846585
    Consulter
  • Late acute renal failure due to bilateral kidney infiltration by ALL as single manifestation of relapse after allogeneic transplantation

    DOI 10.1038/bmt.2009.246 PMID 19767785
    Consulter
  • Munchausen's syndrome in the allogeneic stem cell transplantation setting: a rare but potentially devastating condition

    M-A Archambault-Grenier , Jean Roy , N Beauchemin , Sandra Cohen , Sylvie Lachance , Thomas Kiss
    DOI 10.1038/bmt.2009.192 PMID 19668234
    Consulter
  • NanoLC-MS/MS analyses of urinary desmosine, hydroxylysylpyridinoline and lysylpyridinoline as biomarkers for chronic graft-versus-host disease

    Michel Boutin , Imran Ahmad , Marjo Jauhiainen, Nathalie Lachapelle, Claude Rondeau , Jean Roy , Pierre Thibault
    DOI 10.1021/ac9018796 PMID 19848412
    Consulter
  • Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality

    Waleed Sabry , Richard LeBlanc , Annie-Claude Labbé , Guy Sauvageau , Stephen Couban , Thomas Kiss , Lambert Busque , Sandra Cohen , Sylvie Lachance , Denis-Claude Roy , Jean Roy
    DOI 10.1016/j.bbmt.2009.04.004 PMID 19589481
    Consulter
  • Diphyllobothriasis, a rare cause of profuse diarrhea following autologous transplantation

    DOI 10.1038/bmt.2008.439 PMID 19169286
    Consulter
  • Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy

    Pieter Sonneveld, Roman Hajek, Arnon Nagler, Andrew Spencer, Joan Bladé, Tadeusz Robak, Sen H Zhuang, Jean-Luc Harousseau, Robert Z Orlowski; DOXIL-MMY-3001 Study Investigators , Jean Roy
    DOI 10.1002/cncr.23326 PMID 18300257
    Consulter
  • High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation

    Annie-Claude Labbé, Shi Hann Su, Michel Laverdière, Jacques Pépin, Carlos Patiño , Sandra Cohen , Thomas Kiss , Sylvie Lachance , Guy Sauvageau , Lambert Busque , Denis-Claude Roy , Jean Roy
    DOI 10.1016/j.bbmt.2007.06.013 PMID 17889356
    Consulter
  • Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors

    David S Allan, Pascale Dubé , Jean Roy , Lambert Busque , Denis-Claude Roy
    DOI 10.1016/j.bbmt.2006.11.016 PMID 17382249
    Consulter
  • Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation

    Nathalie Dhédin, Inès Chamakhi, Claude Perreault , Denis-Claude Roy , Guy Sauvageau , Thierry Ducruet , Lambert Busque , Douglas Fish, Robert Bélanger , Jean Roy
    DOI 10.1016/j.exphem.2005.09.013 PMID 16413397
    Consulter
  • Maintaining high autopsy rates in a Canadian blood and marrow transplant program: preserving a diagnostic and research tool

    D S Allan, R Bélanger , Lambert Busque , Sandra Cohen , D Fish , Denis-Claude Roy , Jean Roy
    DOI 10.1038/sj.bmt.1704869 PMID 15735662
    Consulter
  • What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience

    E Simoneau, M Kelly, A C Labbe , Jean Roy , M Laverdière
    DOI 10.1038/sj.bmt.1704793 PMID 15580278
    Consulter
  • Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant

    A Keith Stewart, Christine I Chen, Kang Howson-Jan, Darrell White , Jean Roy , Michael J Kovacs, Chaim Shustik, Anna Sadura, Lois Shepherd, Keyue Ding, Ralph M Meyer, Andrew R Belch
    DOI 10.1158/1078-0432.CCR-04-1106 PMID 15623591
    Consulter
  • Comparative evaluation of three serological methods for detection of human herpesvirus 8-specific antibodies in Canadian allogeneic stem cell transplant recipients

    Yan Sergerie, Yacine Abed , Jean Roy , Guy Boivin
    DOI 10.1128/JCM.42.6.2663-2667.2004 PMID 15184449
    Consulter
  • Is severe intestinal chronic graft-versus-host disease an indication for surgery? A report of two cases

    Andrée-Laure Herr, Jean-François Latulippe, Stéphane Carignan, Andrew Mitchell, Robert Bélanger , Jean Roy
    DOI 10.1097/01.tp.0000127251.16608.8f PMID 15239632
    Consulter
  • Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients

    C Gilbert , Jean Roy , R Belanger, R Delage, C Beliveau, C Demers, G Boivin
    DOI 10.1128/AAC.45.12.3669-3671.2001 PMID 11709367
    Consulter
  • Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect

    Richard LeBlanc , S Montminy-Métivier, R Bélanger , Lambert Busque , D Fish , Denis-Claude Roy , Jeannine Kassis , J Boileau, R Lavallée, D Bélanger, F Letendre , Josée Hébert , Guy Sauvageau , C Perreault , Jean Roy
    DOI 10.1038/sj.bmt.1703253 PMID 11781644
    Consulter
  • Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation

    G Boivin, R Bélanger, R Delage, C Béliveau, C Demers, N Goyette , Jean Roy
    DOI 10.1128/JCM.38.12.4356-4360.2000 PMID 11101564
    Consulter
  • Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease

    S Brochu, B Rioux-Massé , Jean Roy , Denis-Claude Roy , C Perreault
    PMID 10397705
    Consulter
  • A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors

    Richard LeBlanc , Jean Roy , C Demers, L Vu, G Cantin
    DOI 10.1038/sj.bmt.1701756 PMID 10373063
    Consulter
  • All patients with persistent polyclonal B cell lymphocytosis present Bcl-2/Ig gene rearrangements

    R Delage , Jean Roy , L Jacques, A Darveau
    DOI 10.3109/10428199809057616 PMID 9922047
    Consulter
  • Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis

    Jean Roy , C Ryckman, V Bernier, R Whittom, R Delage
    DOI 10.1038/sj.leu.2401040 Abstract PMID 9665185
    Consulter
  • Multiple bcl-2/Ig gene rearrangements in persistent polyclonal B-cell lymphocytosis

    R Delage , Jean Roy , L Jacques, V Bernier, J M Delâge, A Darveau
    DOI 10.1046/j.1365-2141.1997.852725.x PMID 9207405
    Consulter
  • Cytokine expression in human cutaneous chronic graft-versus-host disease

    L A Ochs, B R Blazar , Jean Roy , E B Rest, D J Weisdorf
    PMID 8807119
    Consulter
  • Treatment of essential thrombocythemia during pregnancy with interferon-alpha

    R Delage, C Demers, G Cantin , Jean Roy
    PMID 8677098
    Consulter
  • Granulocyte recovery after sequential transfusion of mobilized blood stem cell concentrates in syngeneic recipients

    G Cantin, R Delage , Jean Roy , D Marchand-Laroche, P F Leblond
    PMID 8704685
    Consulter
  • The tissue expression of cytokines in human acute cutaneous graft-versus-host disease

    Jean Roy , B R Blazar, L Ochs, D J Weisdorf
    DOI 10.1097/00007890-199508270-00008 PMID 7652763
    Consulter
  • The immunopathology of upper gastrointestinal acute graft-versus-host disease. Lymphoid cells and endothelial adhesion molecules

    Jean Roy , J L Platt, D J Weisdorf
    DOI 10.1097/00007890-199303000-00022 PMID 7681225
    Consulter
  • Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy

    Jean Roy , P B McGlave, A H Filipovich, W J Miller, B R Blazar, N K Ramsay, J H Kersey, D J Weisdorf
    PMID 1515883
    Consulter
  • Isolated relapse of acute myelogenous leukemia presenting as a gastric ulcer

    Jean Roy , G Vercellotti, M Fenderson, A Mulvahill, D Snover, D Weisdorf
    DOI 10.1002/ajh.2830370412 PMID 1858786
    Consulter
  • Inflammatory cells in graft-versus-host disease on the rectum: immunopathologic analysis

    S A Weisdorf , Jean Roy , D Snover, J L Platt, D J Weisdorf
    PMID 2070136
    Consulter
  • Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease

    Jean Roy , D Snover, S Weisdorf, A Mulvahill, A Filipovich, D Weisdorf
    DOI 10.1097/00007890-199103000-00019 PMID 2006521
    Consulter